Literature DB >> 1256233

Chemotactic migration of neutrophils under agarose.

T J John, O F Sieber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1256233     DOI: 10.1016/0024-3205(76)90022-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  8 in total

1.  Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator.

Authors:  Glenn M Walker; Jiqing Sai; Ann Richmond; Mark Stremler; Chang Y Chung; John P Wikswo
Journal:  Lab Chip       Date:  2005-04-27       Impact factor: 6.799

2.  Study of Chemotaxis and Cell-Cell Interactions in Cancer with Microfluidic Devices.

Authors:  Jiqing Sai; Matthew Rogers; Kathryn Hockemeyer; John P Wikswo; Ann Richmond
Journal:  Methods Enzymol       Date:  2015-11-24       Impact factor: 1.600

3.  Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes.

Authors:  H Repo; A A Kostiala; T U Kosunen
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

4.  Influence of serum-derived chemotactic factors and bacterial products on human neutrophil chemotaxis.

Authors:  A C Issekutz; W D Biggar
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

5.  Leucocyte motility in the newborn: determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis.

Authors:  H Repo; A M Jokipii; M Leirisalo; T U Kosunen
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

6.  Chemotactic factor produced by Candida albicans.

Authors:  J E Cutler
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  2,6-Di-tert-butyl-4-(2'-thenoyl)phenol(R-830): a novel nonsteroidal anti-inflammatory agent with antioxidant properties.

Authors:  G G Moore; K F Swingle
Journal:  Agents Actions       Date:  1982-12

8.  [Animal experiment studies on the modification of the immune system by ofloxacin].

Authors:  G Pulverer; W Roszkowski; H L Ko; K Roszkowski; J Jeljaszewicz
Journal:  Infection       Date:  1986       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.